Nanomedicine is the application of nanotechnology to medicine and healthcare
Launch of the Call December 2, 2019
Deadline for proposal submission January 21, 2020
Notification of accepted proposals October 2020
Indicative Call budget of TA CR € 1 000 000
Applicants research organizations and enterprises
TA CR Contact Person
+420 234 611 629
- Regenerative medicine (TACR does not support)
- Targeted delivery systems
Belgium, Bulgaria, Canada (Quebec), Czech Republic, Egypt, Estonia, France, Greece, Israel, Italy, Latvia, Lithuania, Norway, Poland, Romania, Slovakia, Spain, Taiwan, Turkey
General conditions for application
A consortium applying to this call will be required to include research group(s) from at least 2 of the 3 following categories, if eligible according to relevant national/regional funding organisations’ regulations for research funding:
- Academia (research teams working in universities, other higher education institutions or research institutes);
- Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of Medical Doctors is encouraged;
- Enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) will be encouraged.
Only transnational projects will be funded. Each consortium submitting a proposal will need to involve a minimum of 3 eligible and a maximum of 5 eligible partners from at least 3 different countries participating to the call (see list below) though no more than 2 eligible partners from the same country participating in the call will be accepted in one consortium.
Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding organisation) may participate in transnational projects if they are able to secure their own funding. However, no more than one research group with own funding can be included in a consortium. The coordinator must be eligible to be funded by the participating funding organisations.
The maximum number of partners will possibly be increased from 5 to 7 (including eligible for funding and non-eligible for funding research groups) if partners from these participating countries, whose scientific community has been under-represented in past EuroNanoMed calls: Bulgaria, Czech Republic, Egypt,Estonia, Latvia, Lithuania, Romania, Slovakia, Taiwan and Turkey:
|Number of partners requesting funding (eligible partners)||3||4||5||6(only with at leastone underrepresented)||7(only with at least 2 underrepresented)|
|Possible number of additional partners with own funding||1||1||1||1||0|
Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed funding organisation respective of the country/region from which applicants have applied. The applications are therefore subject to eligibility criteria of individual funding organisations. Applicants are strongly advised to contact their national representatives as soon as possible in order to confirm their eligibility.
For more information see the Call text.
Partner search tools
Have a look at the European Nanomedicine Map: https://etp-nanomedicine.eu/about-nanomedicine/european-nanomedicine-map/
And use the EuroNanoMed partnering tool: https://www.euronanomed.net/partner-search/list-of-searches-and-offers/
Or use any other H2020 NCP Partner-Search Tools here.
Electronic submission system
Research project consortia who intend to submit a transnational proposal should register at https://ptoutline.eu/app/euronanomed2020, clicking the “to register” button and following the directions. Electronic proposal submission of proposals on the indicated website is mandatory.
About EuroNanoMed 3
EuroNanoMed (ENM) is an ERA-NET on Nanomedicine established since 2008 as a platform for funding agencies and ministries to coordinate research and innovation programmes with the goal of creating and funding collaborative research and innovation projects that can convert research in nanotechnology into practical gains in medicine. Through 10 successful Joint Transnational Calls launched from 2009 to 2019, EuroNanoMed has allocated about 86 Million euros to fund 100 transnational projects in nanomedicine.
EuroNanoMed 3 has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 723770.